Skip to main content
Clinical Trials/JPRN-UMIN000017328
JPRN-UMIN000017328
Completed
Phase 4

Observational study to examine the usefulness of denosumab in postmenopausal breast cancer patients - Observational study to examine the usefulness of denosumab in postmenopausal breast cancer patients

Physician -managed clinical trial0 sites33 target enrollmentMay 1, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
postmenopausal breast cancer patients
Sponsor
Physician -managed clinical trial
Enrollment
33
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2015
End Date
April 30, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Physician -managed clinical trial

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with a history of hypersensitivity to aromatase inhibitors and denosumab 2\.Patients with bone metastases 3\.More than one year have passed after radical surgery. 4\.More than six months have passed after start of denosumab 5\.Patients undergoing treatment with bisphosphonates

Outcomes

Primary Outcomes

Not specified

Similar Trials